Four Health Strategies Help Employers Reduce Costs
A new article highlights four approaches that can help forward-looking employers reduce the costs of healthcare. These strategies include advanced [...]
Whitepaper Highlights the Benefits of Digital Data Collection
Signant Health has published a whitepaper that compares digital data collection with manual methods. A growing number of clinical trial [...]
Three Decades of Democratic Drug Price Control Efforts Face Uncertainty
More than thirty years of drug price regulation efforts by Democrats are facing uncertainty as efforts to pass legislation allowing [...]
ISPOR Article on the Growing Wearable Market and New Applications in Healthcare
A recent article featured in Value & Outcomes Spotlight details the growing use of wearables. These tools can be an [...]
HealthVerity’s RWD Platform Informs Government Response to COVID-19
HealthVerity’s IPGE platform has been a critical source of real world data (RWD) for public health agencies throughout the COVID-19 [...]
Sumitomo Dainippon Pharma and BehaVR announce landmark deal for multiple virtual reality digital therapeutics
OSAKA , Japan and NASHVILLE, Tenn. Sumitomo Dainippon Pharma Co., Ltd. (Head Office: Osaka, Japan ; Representative Director, President and [...]
Register Now for Upcoming October Webinar on RWE in Regulatory Filings
Flatiron Health will hold a webinar detailing how real world evidence (RWE) can be used in regulatory findings. The webinar [...]
EURIPID Survey Shines Spotlight on Drug Price Transparency and Confidential Payer-Pharma Agreements
A recent article, published in Health Policy, highlights the use of confidential managed-entry agreements (MEAs) between payers and pharma throughout [...]
ISPOR Director Discusses Global Commitment to Improving HEOR
Director of Global Networks at the International Society for Pharmacoeconomics and Outcomes (ISPOR) Robert Selby discussed ISPOR’s worldwide initiative intended to [...]
Pear Launches PDT Digest, Highlights the Power of Digital Tools in Improving Patient Outcomes and Reducing Costs
Pear Therapeutics recently launched the Prescription Digital Therapeutics (PDT) Digest, intended to showcase the value of digital tools in improving [...]
ICER’s Final Evidence Report for Two Myasthenia Gravis Therapies Now Available
The Institute for Clinical and Economic Review (ICER) has published its final evidence report for two drugs used to treat [...]
Novo Nordisk teams with CVS Health on obesity support program ahead of Wegovy DTC launch
Novo Nordisk teams with CVS Health on obesity support program ahead of Wegovy DTC launch nmissakian Thu, 10/14/2021 - 16:30 [...]
Pandemic launch woes: Esperion cuts 40% of workforce, goes all in on cholesterol drug’s outcomes trial
Pandemic launch woes: Esperion cuts 40% of workforce, goes all in on cholesterol drug's outcomes trial aliu Mon, 10/18/2021 - [...]
Healthcare marketing firm Relevate Health unveils brand refresh to highlight digital focus
Healthcare marketing firm Relevate Health unveils brand refresh to highlight digital focus nmissakian Wed, 10/13/2021 - 16:53 Read the source [...]
A test of NICE’s resolve: clinical guidelines for Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
The work of the UK’s HTA body, the National Institute for Health and Care Excellence (NICE), is often heatedly debated, [...]
Translating EU presence to US market success
Companies looking to replicate a drug’s EU market success in the US will face significant hurdles unless they are fully [...]
COVID-19 has propelled the regulatory industry years ahead
Janssen’s Saskia De Haes, VP EMEA Regulatory Affairs, looks at how the pandemic response has shaped tomorrow’s regulatory landscape. In [...]
Drug company raises price of suppositories to over $10,000
In 2008, a box of 30 anti-inflammatory rectal suppositories that treats arthritis, called Indocin , had a price tag of [...]
The too-high cost of prescription meds
[Opinion] [Columnists] [Randi F. Marshall] The too-high cost of prescription meds For a moment, let's take the prescription drug debate [...]
Community Access National Network Releases Policy Report on 340 Drug Pricing Program
WASHINGTON , Oct. 19, In 1992, Congress struck a deal with pharmaceutical manufacturers to expand access to care and medication [...]
CVS Caremark’s Lotvin on why the PBM industry is tough for new entrants to crack
Plenty of companies have tried to bring innovation to the pharmacy benefit management industry, but, while many startups rise and [...]
Influence of Chinese National Centralized Drug Procurement on the price of policy-related drugs: an interrupted time series analysis
- Research - Open Access - [Published:] Influence of Chinese National Centralized Drug Procurement on the price of policy-related drugs: [...]
Best and worst states for Medicare prescription drug prices
Maine and Missouri might not stand out as top retirement destinations, but new data suggests that older Americans should consider [...]
Public Opinion on Prescription Drugs and Their Prices
Public Opinion on Prescription Drugs and Their Prices KFF research has consistently found prescription drug costs to be an important [...]
Arthritis Drug Price Spiked 50-Fold; Who Is Monica Gandhi? Public Health in Crisis
Welcome to the latest edition of Investigative Roundup, highlighting some of the best investigative reporting on healthcare each week. Arthritis [...]